ArticleAIDS care2025
Experiences of gender-affirming practices in healthcare settings and HIV testing among transgender and nonbinary young adults in the United States.
Article in AIDS care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Transgender and nonbinary young adults in the United States (U.S.) experience disproportionately high rates of HIV and face unique barriers to accessing HIV testing, a key component of HIV prevention. Gender-affirming practices in healthcare settings may improve care access and reduce care avoidance among transgender and nonbinary people. To our knowledge, no study has examined the association between gender-affirming practices in healthcare settings and HIV testing among transgender and nonbinary U.S. young adults. This study analyzed national cross-sectional, online data from transgender and nonbinary U.S. young adults aged 18-30 years (N = 225) to assess the association between the gender affirmation sub-scale of the Transgender and Gender Diverse Healthcare Discrimination and Adverse Experiences Scale (range: 0-20) and past-year HIV testing using multivariable logistic regression. We found that a one-point increase in the gender affirmation sub-scale score was positively associated with past-year HIV testing (odds ratio = 1.15; 95% confidence interval: 1.06, 1.26), adjusting for age, geographic region, gender identity, educational attainment, employment status, having a usual source of care, and health insurance status. Our findings provide additional evidence that access to gender-affirming healthcare settings is important in facilitating utilization of preventive services among transgender and nonbinary U.S. young adults.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.